Cargando…
Cryptotanshinone Prevents the Binding of S6K1 to mTOR/Raptor Leading to the Suppression of mTORC1-S6K1 Signaling Activity and Neoplastic Cell Transformation
Cryptotanshinone is known for its inhibitory activity against tumorigenesis in various human cancer cells. However, exact mechanisms underlying the anticancer effects of cryptotanshinone are not fully elucidated. Here, we propose a plausible molecular mechanism, wherein cryptotanshinone represses ra...
Autores principales: | Jeoung, Nam Ho, Jeong, Ji Yun, Kang, Bong Seok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Cancer Prevention
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8249204/ https://www.ncbi.nlm.nih.gov/pubmed/34258253 http://dx.doi.org/10.15430/JCP.2021.26.2.145 |
Ejemplares similares
-
RES-529: a PI3K/AKT/mTOR pathway inhibitor that dissociates the mTORC1 and mTORC2 complexes
por: Weinberg, Mark A.
Publicado: (2016) -
Active-Site Inhibitors of mTOR Target Rapamycin-Resistant Outputs of mTORC1 and mTORC2
por: Feldman, Morris E, et al.
Publicado: (2009) -
Perspectives of Targeting mTORC1–S6K1 in Cardiovascular Aging
por: Ming, Xiu-Fen, et al.
Publicado: (2012) -
Conditional Knockout of Raptor/mTORC1 Results in Dentin Malformation
por: Xie, Furong, et al.
Publicado: (2019) -
mTORC2: The other mTOR in autophagy regulation
por: Ballesteros‐Álvarez, Josué, et al.
Publicado: (2021)